BPA Call 36C24122A0144-36C24126N0575

Luminex Corp has been awarded a Blanket Purchase Agreement (BPA) call valued at $92,743.36 for luminex reagents under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII). The contract, executed on August 1, 2024, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order from Veterans Integrated Service Network 1 (VISN 1), the Department of Veterans Affairs' regional network serving veterans across multiple northeastern states....

This federal contract award is for LUMINEX REAGENTS, provided to the Veterans Integrated Service Network 1 (VISN 1) of the U.S. Department of Veterans Affairs. The $89,432.32 firm fixed price contract was awarded to Luminex Corp, a manufacturer of in-vitro diagnostic testing technologies, on August 1, 2023. The contract is a Blanket Purchase Agreement (BPA) call under the GSA Schedule for In-Vitro Diagnostics, Reagents, and Test Kits. The contract has no set-aside designation and is expected...

The Defense Health Agency issued a BPA call to Luminex Corp on March 4, 2026, with a ceiling value of $88,530.00 for Luminex reagents. The call is issued under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test Kits as part of Luminex's $5,762,500 single-award Blanket Purchase Agreement with the Department of the Air Force's 711th Human Performance Wing/USAF School of Aerospace Medicine, which runs through January 31, 2030. Place of performance is Wright-Patterson Air Force Base,...

Luminex Corporation was awarded a $463,944.32 delivery order against the General Services Administration (GSA) Schedule contract for Invitro Diagnostics, Reagents, Test (FSS-65-VII) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. The firm fixed price order is for the delivery of Luminex SAR2 test kits to support COVID-19 testing efforts and has a period of performance through November 11, 2021. No set-aside designation was used for this...

Luminex Corporation was awarded a $54,542.40 firm fixed price blanket purchase agreement call against the General Services Administration Federal Supply Schedule contract for Invitro Diagnostics, Reagents, Test (FSS-65-VII). The contract calls for the delivery of reagents and consumables for Luminex multiplexing technology to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1, with performance taking place in North Providence, Rhode Island. No...

This federal contract award to Luminex Corporation is for the delivery of Luminex reagents under a Blanket Purchase Agreement (BPA) call. The contract, with a ceiling value of $164,760.47, was awarded on August 1, 2021 by the Veterans Integrated Service Network 1 (VISN 1), a division of the Department of Veterans Affairs (VA). The contract is not set aside and is for COVID-19 related requirements, as indicated by the National Interest Action Code. Luminex is a manufacturer of biological...

Luminex Corporation was awarded a $91,000 firm fixed price Blanket Purchase Agreement (BPA) call contract by the Department of Veterans Affairs (VA) to provide Verigene brand reagents and supplies to the Rocky Mountain Regional VA Medical Center in Austin, Texas. The contract was awarded on October 1, 2019 under the VA's Master GSA Schedule for In Vitro Diagnostics, Reagents, and Tests, and has a period of performance through September 30, 2020. No set-aside designation was applied to this BPA...

This is a federal contract award from the Veterans Integrated Service Network 1 (VISN 1), a civilian agency, to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract, valued at $95,000.00, is for the provision of LUMINEX REAGENTS. It is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type and an ultimate completion date of July 31, 2026. The contract is not designated as a set-aside. Luminex Corp, the prime contractor,...

Luminex Corporation was awarded a $90,282 firm fixed price contract by the Department of Veterans Affairs to provide VERIGENE brand reagents and supplies to the Rocky Mountain Regional VA Medical Center in Austin, Texas. The contract was awarded on October 1, 2020 under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, with an end date of September 30, 2021. As the prime contractor, Luminex will deliver test kits and related materials to support clinical operations at the VA...

The Department of Veterans Affairs Veterans Integrated Service Network 4 issued a BPA call to Luminex Corp on July 1, 2025, with a ceiling value of $121,316.10 for PCR testing services. The call is issued under the GSA Federal Supply Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits, a master BPA established July 1, 2023, with a $519,140 ceiling supporting diagnostic testing across the VA Pittsburgh Healthcare System. Performance occurs in Aspinwall, Pennsylvania, with an...